Delivery Order SPE2DB20D2014-SPE2DB25FA89J

Award Date 1/28/25
Potential Completion Date 1/29/25
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,149.20 firm fixed-price delivery order is for 4562474563 ! METHYLERGONOVINE 0.2 MG/ML VLML, with an ultimate completion date of October 16, 2023. This award is associated with Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This $1,270.65 firm fixed-price delivery order contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4566477281 METHYLERGONOVINE 0.2 MG/ML VLML, with a completion date of November 19, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,821.88 Firm Fixed Price Delivery Order is for the supply of 4564841010 - METHYLERGONOVINE 0.2 MG TABLET 28S, with a completion date of June 10, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award is held by Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,196.66, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense. The contract is a Delivery Order (DO) for the supply of 4566548161 - Methylergonovine 0.2 mg/mL, a medication used to treat postpartum hemorrhage. The contract has a firm fixed price and a period of...
This federal contract award, valued at $2,393.28, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567064635 - Methylergonovine 0.2 mg/ml vials, with a final completion date of January 29, 2025. The contract is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,098.80 firm fixed-price delivery order covers the supply of 4567367449 - METHYLPHN ER 27MG 100S, with a period of performance through February 26, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award is for the delivery of METHYLERGONOVINE 0.2 MG/ML VLML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a Delivery Order with a Firm Fixed Price of $5,746.00 and has an Ultimate Completion Date of February 22, 2022. There is no set-aside designation for this award. Amerisourcebergen Drug Corp is a major...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of 4566370474 METHYLERGONOVINE 0.2 MG TABLET 12S, a pharmaceutical product, with a ceiling value of $2,109.54 and a completion date of November 8, 2024. The contract is a Delivery Order, with a Firm Fixed Price pricing type. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,308.90 firm fixed-price delivery order is for the supply of METHYLPHN ER 36MG 100S, a pharmaceutical product. The award has an ultimate completion date of November 12, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $156,868.14, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order that is Firm Fixed Price, with a performance period through December 22, 2022. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB25FA89J
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,196.66 Firm Fixed Price Delivery Order covers the provision of 4567064698 - METHYLERGONOVINE 0.2 MG/ML VLML, with a period of performance through January 29, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award did not utilize any set-aside designations, indicating open competition.

Generated 4/29/25, 9:57 AM